Harly C, Cam M, Kaye J, Bhandoola A. Development and differentiation of early innate lymphoid progenitors. J Exp Med. 2018;215:249-262 pubmed publisher

Flietner E, Wen Z, Rajagopalan A, Jung O, Watkins L, Wiesner J, et al. Ponatinib sensitizes myeloma cells to MEK inhibition in the high-risk VQ model. Sci Rep. 2022;12:10616 pubmed publisher

Potempa M, Aguilar O, Gonzalez Hinojosa M, Tenvooren I, Marquez D, Spitzer M, et al. Influence of Self-MHC Class I Recognition on the Dynamics of NK Cell Responses to Cytomegalovirus Infection. J Immunol. 2022;208:1742-1754 pubmed publisher

Imbert C, Montfort A, Fraisse M, Marcheteau E, Gilhodes J, Martin E, et al. Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1. Nat Commun. 2020;11:437 pubmed publisher

van Stigt Thans T, Akko J, Niehrs A, Garcia Beltran W, Richert L, Stürzel C, et al. Primary HIV-1 Strains Use Nef To Downmodulate HLA-E Surface Expression. J Virol. 2019;93: pubmed publisher